Eden Research (EDEN) Share Price, News & Analysis

Company Overview

Eden Research plc, together with its subsidiaries, develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications under the Mevalone and Cedroz brand names. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products. In addition, the company provides consumer products comprising head-lice treatment products, deodorants, odor neutralizers, fragrances, wound care products, food flavorings, and active ingredient supply/delivery products. Eden Research plc was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

Key Stats

• Today's Range: 3.97 to 4
• 50-Day Range: 3.30 to 4.15
• 52-Week Range: 3.30 to 7
• Volume: 424,752 shs
• Average Volume: 432,183 shs
• Market Capitalization: £21.17 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EDEN Stock Analysis - Frequently Asked Questions

How have EDEN shares performed this year?

Eden Research's stock was trading at GBX 5.75 on January 1st, 2024. Since then, EDEN shares have decreased by 31.0% and is now trading at GBX 3.97.
View the best growth stocks for 2024 here.

How were Eden Research's earnings last quarter?

Eden Research plc (LON:EDEN) posted its quarterly earnings data on Tuesday, September, 29th. The company reported ($0.40) earnings per share (EPS) for the quarter. Eden Research had a negative net margin of 38.70% and a negative trailing twelve-month return on equity of 17.27%.

How do I buy shares of Eden Research?

Shares of EDEN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Eden Research own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Eden Research investors own include Kromek Group (KMK), Primary Health Properties (PHP), National Grid (NG.L), Cabot Energy (CAB), EPE Special Opportunities (ESO), Marston's (MARS) and Mothercare (MTC).

Company Calendar

• Last Earnings: 9/29/2020
• Today: 11/21/2024

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Basic Materials
• Industry: Agricultural Inputs
• Sub-Industry: N/A
• Current Symbol: LON:EDEN
• CUSIP: N/A
• CIK: N/A
• Web: www.edenresearch.com
• Phone: +44-1285-359555
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-1,520,000.00
• Net Margins: -38.70%
• Pretax Margin: N/A
• Return on Equity: -17.27%
• Return on Assets: -11.29%

Debt

• Debt-to-Equity Ratio: 1.25
• Current Ratio: 3.80
• Quick Ratio: 2.42

Sales & Book Value

• Annual Sales: £3.94 million
• Price / Sales: 5.27
• Cash Flow: GBX 0.33 per share
• Price / Cash Flow: 11.90
• Book Value: GBX 2 per share
• Price / Book: 1.95

Miscellaneous

• Outstanding Shares: 533,350,000
• Free Float: N/A
• Market Cap: £20.75 million
• Optionable: Not Optionable
• Beta: 0.92